Skip to main content

Advertisement

Log in

Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis

  • Clinical Trial
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

In ten patients with mild to moderate clinical relapses of ulcerative colitis during treatment with mesalazine (1 g t.i.d.) and with a previous history of poorly tolerated steroid courses, transdermal nicotine (15 mg daily) was added for 4 weeks. Clinical findings were assessed by employing Rachmilewitz's activity index. In 7 of the patients, clinical remission was achieved, the results persisting for up to 3 months after nicotine withdrawal. Endoscopic and histological examination, when performed, confirmed the clinical findings. Nicotine patches may represent a good alternative to steroids in selected patients with mild to moderate relapses of ulcerative colitis. The precise mechanism of action remains unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841–1854.

    Article  CAS  PubMed  Google Scholar 

  2. Jick H, Walker A. Cigarette smoking and ulcerative colitis. N Engl J Med 1983;308:261–263.

    CAS  PubMed  Google Scholar 

  3. Rudra T, Motley RJ, Rhodes J. Does, smoking improve colitis? Scand J Gastroenterol 1989;24:61–63.

    Google Scholar 

  4. Lashner BA, Hanauer SB, Silverstein MD. Testing nicotine gum for ulcerative colitis patients. Experience with single-patient trials. Dig Dis Sci 1990;35:827–832.

    CAS  PubMed  Google Scholar 

  5. Srivastava ED, Russell MAH, Feyerabend C et al. Transdermal nicotine in active ulcerative colitis. Eur J Gastroenterol Hepatol 1991;3:815–818.

    Google Scholar 

  6. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811–815.

    Article  CAS  PubMed  Google Scholar 

  7. Guslandi M, Tittobello A. Steroid-sparing effect of transdermal nicotine in ulcerative colitis. J Clin Gastroenterol 1994;18:347–348.

    CAS  PubMed  Google Scholar 

  8. Rachmilewitz D. Coated mesalazine (5-aminosalycilic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. Br Med J 1989;298:82–86.

    CAS  Google Scholar 

  9. Thomas GAO, Rhodes J, Mani V, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995;332:988–992.

    Article  CAS  PubMed  Google Scholar 

  10. Zijistra FJ, Srivastava ED, Rhodes M et al. Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut 1994;35:247–251.

    Google Scholar 

  11. Srivastava ED, Russell MA, Feyerabend C et al. Effect of ulcerative colitis and smoking on rectal blood flow. Gut 1990;31:1021–1024.

    CAS  PubMed  Google Scholar 

  12. Guslandi M, Polli D, Sorghi M, et al. Rectal blood flow in ulcerative colitis. Am J Gastroenterol 1995;90:579–580.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guslandi, M., Tittobello, A. Pilot trial of nicotine patches as an alternative to corticosteroids in ulcerative colitis. J Gastroenterol 31, 627–629 (1996). https://doi.org/10.1007/BF02355071

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02355071

Key words

Navigation